Acasti Pharma reported $-0.36 in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Acasti Pharma USD -0.36 172K Dec/2024
Addus HomeCare USD 760K 177K Sep/2025
Amarin USD 3.37M 3.37M Dec/2024
Cassava Sciences USD 1.17M 47K Sep/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Tilray USD 12.83M 20.19M May/2024